REFERENCES
- de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341:1368–1378.
- Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF. Outcome of treatment for distal bile duct cancer. Br J Surg. 1996;83:1712–1715.
- Hezel AF, Zhu AX. Systemic therapy for biliary tract cancers. Oncologist. 2008;13:415–423.
- Bengala C, Bertolini F, Malavasi N, Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer. 2010;102:68–72.
- Khan SA, Davidson BR, Goldin R, Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(Suppl 6):VI1–VI9.
- Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg. 1991;161:454–458.
- Hoang BX, Le BT, Tran HD, Dimethyl sulfoxide-sodium bicarbonate infusion for palliative care and pain relief in patients with metastatic prostate cancer. J Pain Palliat Care Pharmacother. 2011;25:350–355.
- Hoang BX, Tran DM, Tran HQ, Dimethyl sulfoxide and sodium bicarbonate in the treatment of refractory cancer pain. J Pain Palliat Care Pharmacother. 2011;25:19–24.
- Bottiglieri, T. S-adenosyl-l-methionine (SAMe): from the bench to the bedside—molecular basis of a pleiotrophic molecule. Am J Clin Nutr. 2002;76:1151S–1157S.
- Lineva OI, Osadchenko, E, Nesterenko SA. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome]. Klin Med (Mosk). 1998;76:45–48.
- Frezza M, Centini G, Cammareri G, Le Grazie, C, Di Padova, C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology. 1990;37(Suppl 2):122–125.
- Valle J, Wasan H, Palmer DH, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–1281.
- Lee JK, Capanu M, O'Reilly EM, A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. Br J Cancer. 2013;109:915–919.
- Luo J, Li YN, Wang F, Zhang WM, Geng, X. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. Int J Biol Sci. 2010;6:784–795.
- Hoang BX, Graeme Shaw D, Pham, P, Levine SA. Neuro-bioenergetic concepts in cancer prevention and treatment. Med Hypotheses. 2007;68:832–843.
- Hoang BX, Levine SA, Shaw DG, Dimethyl sulfoxide as an excitatory modulator and its possible role in cancer pain management. Inflamm Allergy Drug Targets. Nov. 4, 2010;9: 306–12.
- Akaike A, Tamura Y, Sato, Y, Yokota, T. Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur J Pharmacol. 1993;241:1–6.
- Travagli RA, Gillis RA, Kellar KJ. S-adenosyl-l-methionine modulates firing rate of dorsal motor nucleus of the vagus neurones in vitro. Eur J Pharmacol. 1994;264:385–390.